Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (100601)	2/7/2002 10:15:03 AM
From: Chuca Marsh	Read Replies (1) \| Respond to of 150070

Ecellent TBIN, I bot a few days ago, also news BCR brok TYC merger LOL see my TGL entry : Ask was PRE OPEN at $100 Bid $49 the opened at $52: NOT TIED to TYC will go $65 in a week IMHO- same (increase )rates on TBIN I hope. Bard and Tyco Terminate Merger Agreement MURRAY HILL, N.J., Feb 6, 2002 (BW HealthWire) -- C. R. Bard, Inc. (NYSE:BCR)today announced that Bard and Tyco International Ltd. have mutually agreed toterminate their merger agreement.Bard also stated that in connection with the termination, each party will bearits own costs and expenses."We have always acted in the best interest of our shareholders," commentedWilliam H. Longfield, Bard's chairman and chief executive officer. "We nowbelieve that the best course of action for our shareholders, as well as ouremployees, is for Bard to remain an independent company. Our business is healthyand viable. Bard's management team remains intact. Our recent financialperformance has been excellent and our outlook is positive. We will becommunicating more detailed information on our future outlook within a fewdays."C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey, isa leading multinational developer, manufacturer and marketer of health careproducts in the fields of vascular, urology, oncology and surgical specialtyproducts.CONTACT: Investor Relations:Todd C. Schermerhorn, 908/277-8139orMedia Relations:Holly P. Glass, 703/754-2848URL: businesswire.comtoday's News On The Net - Business Wire's full file on the Internetwith Hyperlinks to your home page.Copyright (C) 2002 Business Wire. All rights reserved.KEYWORD: NEW JERSEYINDUSTRY KEYWORD: MANUFACTURINGMEDICALMEDICALDEVICESMERGERS/ACQSOURCE:C.R.Bard,Inc. Chucka